Some clinicians recommend a microdosing approach to tirzepatide for patients who are particularly sensitive to side effects
An invited commentary on this study, also published in JAMA Ophthalmology, challenges the idea that the increased risk of NAION among semaglutide users resulted directly from the medication
Preclinical Pharmacology Comprehensive preclinical studies in diet-induced obese mice, diabetic mouse models, and non-human primates established the pharmacological proof of concept
However, the authors urge caution in interpreting these findings due to the limited number of trials, the variations in study designs, and the heterogeneity in patient populations and substance types studied
Athletes often report quicker recovery from strains, tears, and overtraining when using this peptide